Correction to UV yeast regulation: what food and supplement manufacturers must review

Key data

If your company manufactures or markets food products or supplements that incorporate baker's yeast (Saccharomyces cerevisiae) treated with UV as a source of vitamin D, there is a regulatory change you need to know about. The European Commission published on 8 September 2026 a rectification to the Commission Implementing Regulation (EU) 2022/196, which previously authorized the extension of use and modified the specifications of this ingredient as a novel food under the framework of Regulation (EU) 2015/2283.

The correction amends material errors in the original text published in the Official Journal of the European Union on 14 February 2022. This means that the text that has been in force since that date contained inaccuracies, and the corrected text is the one with legal validity. For any company operating with this ingredient, the correct regulatory reference is now the rectified version.

What does this regulation establish?

The Commission Implementing Regulation (EU) 2022/196 authorized two specific things regarding UV-treated baker's yeast:

• The extension of use of this ingredient as a novel food, expanding the categories of products in which it can be incorporated.
• The modification of technical specifications of the ingredient, updating the parameters that must be met for its authorized use.

All within the framework of novel foods, regulated by Regulation (EU) 2015/2283, which requires express authorization from the Commission before a non-traditional ingredient can be marketed in the EU. Commission Implementing Regulation (EU) 2022/196 also modified the Commission Implementing Regulation (EU) 2017/2470, which is the Union list of authorized novel foods.

The rectification published now corrects material errors detected in that original text. This is not a policy change or a new authorization: it is a technical correction that affects the literal content of the regulation. The practical impact is limited but relevant for those operating with this ingredient, since the corrected text is the legally valid one.

Economic and operational impact

The direct economic impact of this rectification is limited: it does not introduce new fees, does not modify prices or tariffs, and does not change the authorization status of the ingredient. UV-treated baker's yeast remains an authorized novel food.

However, the operational impact can be relevant in two specific areas:

• Labeling: If the corrected technical specifications differ from the originals in parameters that are reflected on the label (ingredient name, conditions of use, vitamin D levels), current labeling may not comply with the valid text.
• Technical documentation and product sheets: The ingredient specifications that appear in internal documentation, supplier contracts, or notifications to health authorities must reference the corrected text, not the original.

The cost of not acting can materialize in observations or requirements from food control authorities during inspections, especially if the labeling or technical documentation cites the original text with errors.

Who does it affect?

• Manufacturers of food supplements that incorporate baker's yeast (Saccharomyces cerevisiae) treated with UV as a source of vitamin D.
• Manufacturers of fortified foods with this ingredient (breads, cereals, dairy products or others where its use has been authorized).
• Distributors and marketers of products containing this novel food in the European market.
• Quality, regulatory and labeling departments of food sector companies that manage compliance with novel food regulations.
• Regulatory advisors and food law consultants who advise companies in the sector.

Practical example

A manufacturer of vitamin supplements that markets vitamin D capsules made with UV-treated baker's yeast (Saccharomyces cerevisiae) has in its product technical sheet a reference to the Commission Implementing Regulation (EU) 2022/196 with the ingredient specifications as published on 14 February 2022.

Following the publication of this rectification on 8 September 2026, that technical sheet may contain incorrect data if the material errors corrected affect the technical parameters of the ingredient. The regulatory department must:

1. Download the corrected text from the Official Journal of the EU.
2. Compare the corrected specifications with those in its internal documentation.
3. Update the technical sheet and, if necessary, the labeling before the next inspection or record renewal.

What should companies do now?

1. Download and read the corrected text: Access the full text of the rectification published on 8 September 2026 in the Official Journal of the EU to identify exactly what errors have been corrected.
2. Compare with the original text from February 2022: Review the original Commission Implementing Regulation (EU) 2022/196 and contrast the differences point by point.
3. Audit internal technical documentation: Verify that ingredient technical sheets, regulatory dossiers, and supplier contracts reflect the correct specifications according to the corrected text.
4. Review product labeling: Check whether any data on current labeling (name, conditions of use, vitamin D levels) is affected by the corrected errors.
5. Update regulatory references: Ensure that any internal or external reference to Regulation (EU) 2022/196 points to the corrected text, not the original with errors.
6. Inform suppliers and customers if appropriate: If the ingredient is supplied or received from third parties, communicate the change to ensure documentary traceability throughout the chain.

Official source

Consult full regulation in official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202690746